Biomarkers for Response to Anti–PD-1/Anti–PD-L1 Immune Checkpoint Inhibitors: A Large Meta-Analysis
ByArshiya Mariam, BS,Suneel D. Kamath, MD,Kimberly Schveder, MS,Howard L. McLeod, PharmD,Daniel M. Rotroff, PhD
Published: | Updated:
Arshiya Mariam, BS, and colleagues report the findings of a large meta-analysis assessing the ability of various biomarkers to predict responses to immune checkpoint inhibition.
